Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bahil Ghanim

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Cancers|January 11, 2024
Validation of Inflammatory Prognostic Biomarkers in Pleural MesotheliomaStephanie Iser, Sarah Hintermair, Alexander Varga, et al.
Annals of Surgery|July 4, 2012
Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysisBahil Ghanim, Mir Alireza Hoda, Max-Paul Winter, et al.
The European Respiratory Journal|July 22, 2017
Hypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phoxChandran Nagaraj, Christoph Tabeling, Bence M Nagy, et al.
American Journal of Respiratory and Critical Care Medicine|November 3, 2017
Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF DisinhibitionDiana Zabini, Elise Granton, Yijie Hu, et al.
The European Respiratory Journal|July 20, 2019
IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosisAnna Birnhuber, Slaven Crnkovic, Valentina Biasin, et al.
Scientific Reports|April 3, 2020
Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion: the impact of C-reactive protein and immune-checkpoint inhibitionBahil Ghanim, Anna Rosenmayr, Paul Stockhammer, et al.
Scientific Reports|November 30, 2017
Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesotheliomaThomas Klikovits, Paul Stockhammer, Viktoria Laszlo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2014
Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapyMihaly Cserepes, Gyula Ostoros, Zoltan Lohinai, et al.
American Journal of Respiratory and Critical Care Medicine|December 18, 2018
Disconnect between Fibrotic Response and Right Ventricular DysfunctionSlaven Crnkovic, Bakytbek Egemnazarov, Rachel Damico, et al.
Scientific Reports|October 4, 2017
Intrathoracic solitary fibrous tumor - an international multicenter study on clinical outcome and novel circulating biomarkersBahil Ghanim, Sebastian Hess, Pietro Bertoglio, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Cancers|January 11, 2024
Validation of Inflammatory Prognostic Biomarkers in Pleural MesotheliomaStephanie Iser, Sarah Hintermair, Alexander Varga, et al.
Annals of Surgery|July 4, 2012
Pretreatment serum C-reactive protein levels predict benefit from multimodality treatment including radical surgery in malignant pleural mesothelioma: a retrospective multicenter analysisBahil Ghanim, Mir Alireza Hoda, Max-Paul Winter, et al.
The European Respiratory Journal|July 22, 2017
Hypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phoxChandran Nagaraj, Christoph Tabeling, Bence M Nagy, et al.
American Journal of Respiratory and Critical Care Medicine|November 3, 2017
Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF DisinhibitionDiana Zabini, Elise Granton, Yijie Hu, et al.
The European Respiratory Journal|July 20, 2019
IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosisAnna Birnhuber, Slaven Crnkovic, Valentina Biasin, et al.
Scientific Reports|April 3, 2020
Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion: the impact of C-reactive protein and immune-checkpoint inhibitionBahil Ghanim, Anna Rosenmayr, Paul Stockhammer, et al.
Scientific Reports|November 30, 2017
Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesotheliomaThomas Klikovits, Paul Stockhammer, Viktoria Laszlo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2014
Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapyMihaly Cserepes, Gyula Ostoros, Zoltan Lohinai, et al.
American Journal of Respiratory and Critical Care Medicine|December 18, 2018
Disconnect between Fibrotic Response and Right Ventricular DysfunctionSlaven Crnkovic, Bakytbek Egemnazarov, Rachel Damico, et al.
Scientific Reports|October 4, 2017
Intrathoracic solitary fibrous tumor - an international multicenter study on clinical outcome and novel circulating biomarkersBahil Ghanim, Sebastian Hess, Pietro Bertoglio, et al.
Pageof 6